Brain cholesterol in normal and pathological aging

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 8, 2010, Pages 934-944

  Martin, Mauricio ^a,b   Dotti, Carlos G ^a,b,c   Ledesma, Maria Dolores ^c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

aging; Alzheimer's disease; brain; Cholesterol; CYP46

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CYTOCHROME P450; DESMOSTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

AGING; ALZHEIMER DISEASE; ASTROCYTE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; DOWN REGULATION; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; LIPID TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REGULATORY MECHANISM; REVIEW; UPREGULATION;

AGING; ANIMALS; BRAIN; CHOLESTEROL; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES;

EID: 77953269718     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.03.011     Document Type: Review

References (187)

1. Haines T.H. Do sterols reduce proton and sodium leaks through lipid bilayers?. Prog. Lipid Res. 40 (2001) 299-324
2. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000) 31-39
3. Parton R.G., and Hancock J.F. Lipid rafts and plasma membrane microorganization: insights from Ras. Trends Cell Biol. 14 (2004) 141-147
4. Martin M.G., Perga S., Trovo L., Rasola A., Holm P., Rantamaki T., Harkany T., Castren E., Chiara F., and Dotti C.G. Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol. Biol. Cell 19 (2008) 2101-2112
5. Miller W.L. Structure of genes encoding steroidogenic enzymes. J. Steroid Biochem. 27 (1987) 759-766
6. Hemming F.W. The biosynthesis of polyisoprenoid chains. Biochem. Soc. Trans. 11 (1983) 497-504
7. Rikitake Y., and Liao J.K. Rho GTPases, statins, and nitric oxide. Circ. Res. 97 (2005) 1232-1235
8. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12 (2001) 105-112
9. Snipes G.J., and Suter U. Cholesterol and myelin. Subcell. Biochem. 28 (1997) 173-204
10. Jurevics H., and Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64 (1995) 895-901
11. Chobanian A.V., Burrows B.A., and Hollander W. Body cholesterol metabolism in man. II. Measurement of the body cholesterol miscible pool and turnover rate. J. Clin. Invest. 41 (1962) 1738-1744
12. Meaney S., Hassan M., Sakinis A., Lutjohann D., von Bergmann K., Wennmalm A., Diczfalusy U., and Bjorkhem I. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. J. Lipid Res. 42 (2001) 70-78
13. Plotz E.J., Kabara J.J., Davis M.E., LeRoy G.V., and Gould R.G. Studies on the synthesis of cholesterol in the brain of the human fetus. Am. J. Obstet. Gynecol. 101 (1968) 534-538
14. Gardner R.G., and Hampton R.Y. A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes. J. Biol. Chem. 274 (1999) 31671-31678
15. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 9 (2003) 94-101
16. Reynolds G.A., Basu S.K., Osborne T.F., Chin D.J., Gil G., Brown M.S., Goldstein J.L., and Luskey K.L. HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38 (1984) 275-285
17. Waterham H.R., Koster J., Romeijn G.J., Hennekam R.C., Vreken P., Andersson H.C., FitzPatrick D.R., Kelley R.I., and Wanders R.J. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 69 (2001) 685-694
18. Saito M., Benson E.P., and Rosenberg A. Metabolism of cholesterol and triacylglycerol in cultured chick neuronal cells, glial cells, and fibroblasts: accumulation of esterified cholesterol in serum-free culture. J. Neurosci. Res. 18 (1987) 319-325
19. Heacock A.M., Klinger P.D., Seguin E.B., and Agranoff B.W. Cholesterol synthesis and nerve regeneration. J. Neurochem. 42 (1984) 987-993
20. Hayashi H., Campenot R.B., Vance D.E., and Vance J.E. Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J. Biol. Chem. 279 (2004) 14009-14015
21. Fan Q.W., Yu W., Gong J.S., Zou K., Sawamura N., Senda T., Yanagisawa K., and Michikawa M. Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons. J. Neurochem. 80 (2002) 178-190
22. Goritz C., Mauch D.H., and Pfrieger F.W. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol. Cell. Neurosci. 29 (2005) 190-201
23. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
24. Pfrieger F.W. Role of cholesterol in synapse formation and function. Biochim. Biophys. Acta 1610 (2003) 271-280
25. Pfrieger F.W. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?. BioEssays 25 (2003) 72-78
26. Nieweg K., Schaller H., and Pfrieger F.W. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 109 (2009) 125-134
27. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., and Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76 (1985) 1501-1513
28. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., Hajian H., and Finch C.E. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143 (1997) 313-318
29. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
30. Metzger R.E., LaDu M.J., Pan J.B., Getz G.S., Frail D.E., and Falduto M.T. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 372-380
31. Xu P.T., Gilbert J.R., Qiu H.L., Ervin J., Rothrock-Christian T.R., Hulette C., and Schmechel D.E. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 154 (1999) 601-611
32. Dietschy J.M., and Turley S.D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45 (2004) 1375-1397
33. Dietschy J.M., Kita T., Suckling K.E., Goldstein J.L., and Brown M.S. Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors. J. Lipid Res. 24 (1983) 469-480
34. Bjorkhem I., and Diczfalusy U. 24(S), 25-epoxycholesterol-a potential friend. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2209-2210
35. Bjorkhem I., Andersson U., Ellis E., Alvelius G., Ellegard L., Diczfalusy U., Sjovall J., and Einarsson C. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J. Biol. Chem. 276 (2001) 37004-37010
36. Bjorkhem I., Lutjohann D., Diczfalusy U., Stahle L., Ahlborg G., and Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39 (1998) 1594-1600
37. Bjorkhem I., Lutjohann D., Breuer O., Sakinis A., and Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol. Chem. 272 (1997) 30178-30184
38. Lutjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., and Bjorkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9799-9804
39. Li-Hawkins J., Lund E.G., Bronson A.D., and Russell D.W. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J. Biol. Chem. 275 (2000) 16543-16549
40. Lund E.G., Guileyardo J.M., and Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7238-7243
41. Ramirez D.M., Andersson S., and Russell D.W. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 507 (2008) 1676-1693
42. Bogdanovic N., Bretillon L., Lund E.G., Diczfalusy U., Lannfelt L., Winblad B., Russell D.W., and Bjorkhem I. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314 (2001) 45-48
43. Jessup W., Gelissen I.C., Gaus K., and Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 17 (2006) 247-257
44. Kim W.S., Rahmanto A.S., Kamili A., Rye K.A., Guillemin G.J., Gelissen I.C., Jessup W., Hill A.F., and Garner B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J. Biol. Chem. 282 (2007) 2851-2861
45. Kim W.S., Guillemin G.J., Glaros E.N., Lim C.K., and Garner B. Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. NeuroReport 17 (2006) 891-896
46. Pohl A., Devaux P.F., and Herrmann A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim. Biophys. Acta 1733 (2005) 29-52
47. Nakamura K., Kennedy M.A., Baldan A., Bojanic D.D., Lyons K., and Edwards P.A. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279 (2004) 45980-45989
48. Tachikawa M., Watanabe M., Hori S., Fukaya M., Ohtsuki S., Asashima T., and Terasaki T. Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J. Neurochem. 95 (2005) 294-304
49. Wahrle S.E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J.D., Kowalewski T., and Holtzman D.M. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279 (2004) 40987-40993
50. Xu Q., Li Y., Cyras C., Sanan D.A., and Cordell B. Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle. J. Biol. Chem. 275 (2000) 31770-31777
51. Xie C., Lund E.G., Turley S.D., Russell D.W., and Dietschy J.M. Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44 (2003) 1780-1789
52. Lund E.G., Xie C., Kotti T., Turley S.D., Dietschy J.M., and Russell D.W. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278 (2003) 22980-22988
53. Kotti T.J., Ramirez D.M., Pfeiffer B.E., Huber K.M., and Russell D.W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3869-3874
54. Drachman D.A., Glosser G., Fleming P., and Longenecker G. Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 32 (1982) 944-950
55. Schonfield A.E., Davidson H., and Jones H. An example of age-associated interference in memorizing. J. Gerontol. 38 (1983) 204-210
56. Burke S.N., and Barnes C.A. Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7 (2006) 30-40
57. Driscoll I., Howard S.R., Stone J.C., Monfils M.H., Tomanek B., Brooks W.M., and Sutherland R.J. The aging hippocampus: a multi-level analysis in the rat. Neuroscience 139 (2006) 1173-1185
58. Morrison J.H., and Hof P.R. Life and death of neurons in the aging brain. Science 278 (1997) 412-419
59. Svennerholm L., Bostrom K., Jungbjer B., and Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J. Neurochem. 63 (1994) 1802-1811
60. Hattiangady B., Rao M.S., Shetty G.A., and Shetty A.K. Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. Exp. Neurol. 195 (2005) 353-371
61. Mattson M.P., and Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7 (2006) 278-294
62. Shetty A.K., Rao M.S., Hattiangady B., Zaman V., and Shetty G.A. Hippocampal neurotrophin levels after injury: Relationship to the age of the hippocampus at the time of injury. J. Neurosci. Res. 78 (2004) 520-532
63. Silhol M., Bonnichon V., Rage F., and Tapia-Arancibia L. Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats. Neuroscience 132 (2005) 613-624
64. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 (2004) S18-S25 Suppl
65. Balaban R.S., Nemoto S., and Finkel T. Mitochondria, oxidants, and aging. Cell 120 (2005) 483-495
66. Benn S.C., and Woolf C.J. Adult neuron survival strategies-slamming on the brakes. Nat. Rev. Neurosci. 5 (2004) 686-700
67. Schmitt C.A. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nat. Rev. Cancer 3 (2003) 286-295
68. Soderberg M., Edlund C., Kristensson K., and Dallner G. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54 (1990) 415-423
69. Igbavboa U., Avdulov N.A., Chochina S.V., and Wood W.G. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J. Neurochem. 69 (1997) 1661-1667
70. Wood W.G., Schroeder F., Avdulov N.A., Chochina S.V., and Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 34 (1999) 225-234
71. Kabara J.J. A critical review of brain cholesterol metabolism. Prog. Brain Res. 40 (1973) 363-382
72. Zhang Y., Appelkvist E.L., Kristensson K., and Dallner G. The lipid compositions of different regions of rat brain during development and aging. Neurobiol. Aging 17 (1996) 869-875
73. Bu G., Maksymovitch E.A., Nerbonne J.M., and Schwartz A.L. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269 (1994) 18521-18528
74. Runquist M., Parmryd I., Thelin A., Chojnacki T., and Dallner G. Distribution of branch point prenyltransferases in regions of bovine brain. J. Neurochem. 65 (1995) 2299-2306
75. Thelen K.M., Falkai P., Bayer T.A., and Lutjohann D. Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci. Lett. 403 (2006) 15-19
76. Blalock E.M., Chen K.C., Sharrow K., Herman J.P., Porter N.M., Foster T.C., and Landfield P.W. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 23 (2003) 3807-3819
77. Matthies Jr. H., Schulz S., Hollt V., and Krug M. Inhibition by compactin demonstrates a requirement of isoprenoid metabolism for long-term potentiation in rat hippocampal slices. Neuroscience 79 (1997) 341-346
78. Riddell D.R., Zhou H., Atchison K., Warwick H.K., Atkinson P.J., Jefferson J., Xu L., Aschmies S., Kirksey Y., Hu Y., Wagner E., Parratt A., Xu J., Li Z., Zaleska M.M., Jacobsen J.S., Pangalos M.N., and Reinhart P.H. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 28 (2008) 11445-11453
79. Gong J.S., Kobayashi M., Hayashi H., Zou K., Sawamura N., Fujita S.C., Yanagisawa K., and Michikawa M. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J. Biol. Chem. 277 (2002) 29919-29926
80. Walker L.C., Parker C.A., Lipinski W.J., Callahan M.J., Carroll R.T., Gandy S.E., Smith J.D., Jucker M., and Bisgaier C.L. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am. J. Pathol. 151 (1997) 1371-1377
81. Robertson T.A., Dutton N.S., Martins R.N., Roses A.D., Kakulas B.A., and Papadimitriou J.M. Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice. Neuroscience 82 (1998) 171-180
82. Cambon K., Davies H.A., and Stewart M.G. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice. Neuroscience 97 (2000) 685-692
83. Moghadasian M.H., McManus B.M., Nguyen L.B., Shefer S., Nadji M., Godin D.V., Green T.J., Hill J., Yang Y., Scudamore C.H., and Frohlich J.J. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J. 15 (2001) 2623-2630
84. Anderson R., Barnes J.C., Bliss T.V., Cain D.P., Cambon K., Davies H.A., Errington M.L., Fellows L.A., Gray R.A., Hoh T., Stewart M., Large C.H., and Higgins G.A. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience 85 (1998) 93-110
85. Bronfman F.C., Tesseur I., Hofker M.H., Havekens L.M., and Van Leuven F. No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice. Neuroscience 97 (2000) 411-418
86. Puolivali J., Miettinen R., Pradier L., and Riekkinen Jr. P. Apolipoprotein E-deficient mice are not more susceptible to the biochemical and memory deficits induced by nucleus basalis lesion. Neuroscience 96 (2000) 291-297
87. Krzywkowski P., Ghribi O., Gagne J., Chabot C., Kar S., Rochford J., Massicotte G., and Poirier J. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice. Neuroscience 92 (1999) 1273-1286
88. Oitzl M.S., Mulder M., Lucassen P.J., Havekes L.M., Grootendorst J., and de Kloet E.R. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752 (1997) 189-196
89. Gordon I., Grauer E., Genis I., Sehayek E., and Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199 (1995) 1-4
90. Chapman S., Sabo T., Roses A.D., and Michaelson D.M. Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice. Neuroscience 97 (2000) 419-424
91. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., and Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136 (1995) 107-122
92. Veinbergs I., Mante M., Jung M.W., Van Uden E., and Masliah E. Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 23 (1999) 519-531
93. Veinbergs I., Jung M.W., Young S.J., Van Uden E., Groves P.M., and Masliah E. Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci. Lett. 249 (1998) 71-74
94. Krugers H.J., Mulder M., Korf J., Havekes L., de Kloet E.R., and Joels M. Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. NeuroReport 8 (1997) 2505-2510
95. Gee J.R., Ding Q., and Keller J.N. Modulation of apolipoprotein E and interleukin-1beta in the aging liver. Exp. Gerontol. 40 (2005) 409-415
96. Jiang C.H., Tsien J.Z., Schultz P.G., and Hu Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1930-1934
97. Terao A., Apte-Deshpande A., Dousman L., Morairty S., Eynon B.P., Kilduff T.S., and Freund Y.R. Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 132 (2002) 99-112
98. Morgan T.E., Xie Z., Goldsmith S., Yoshida T., Lanzrein A.S., Stone D., Rozovsky I., Perry G., Smith M.A., and Finch C.E. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience 89 (1999) 687-699
99. Pasinetti G.M., Hassler M., Stone D., and Finch C.E. Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions. Synapse 31 (1999) 278-284
100. Gee J.R., Ding Q., and Keller J.N. Age-related alterations of Apolipoprotein E and interleukin-1beta in the aging brain. Biogerontology 7 (2006) 69-79
101. Kadish I., Thibault O., Blalock E.M., Chen K.C., Gant J.C., Porter N.M., and Landfield P.W. Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J. Neurosci. 29 (2009) 1805-1816
102. Martin M.G., Trovo L., Perga S., Sadowska A., Rasola A., Chiara F., and Dotti C.G. Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons. Neurobiol. Aging (2009) doi:10.1016/j.neurobiolaging.2009.04.022
103. Halford R.W., and Russell D.W. Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 3502-3506
104. Ohyama Y., Meaney S., Heverin M., Ekstrom L., Brafman A., Shafir M., Andersson U., Olin M., Eggertsen G., Diczfalusy U., Feinstein E., and Bjorkhem I. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J. Biol. Chem. 281 (2006) 3810-3820
105. Teunissen C.E., Floris S., Sonke M., Dijkstra C.D., De Vries H.E., and Lutjohann D. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 85 (2007) 1499-1505
106. Cartagena C.M., Ahmed F., Burns M.P., Pajoohesh-Ganji A., Pak D.T., Faden A.I., and Rebeck G.W. Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J. Neurotrauma 25 (2008) 1087-1098
107. Milagre I., Nunes M.J., Gama M.J., Silva R.F., Pascussi J.M., Lechner M.C., and Rodrigues E. Transcriptional regulation of the human CYP46A1 brain-specific expression by Sp transcription factors. J. Neurochem. 106 (2008) 835-849
108. Shafaati M., O'Driscoll R., Bjorkhem I., and Meaney S. Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors. Biochem. Biophys. Res. Commun. 378 (2009) 689-694
109. Bjorkhem I. Are side-chain oxidized oxysterols regulators also in vivo?. J. Lipid Res. 50 (2009) S213-S218 Suppl
110. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., and Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 (1996) 728-731
111. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997) 3137-3140
112. Edwards P.A., Kennedy M.A., and Mak P.A. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul. Pharmacol. 38 (2002) 249-256
113. Repa J.J., and Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16 (2000) 459-481
114. Whitney K.D., Watson M.A., Collins J.L., Benson W.G., Stone T.M., Numerick M.J., Tippin T.K., Wilson J.G., Winegar D.A., and Kliewer S.A. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16 (2002) 1378-1385
115. Fitzgerald M.L., Okuhira K., Short III G.F., Manning J.J., Bell S.A., and Freeman M.W. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J. Biol. Chem. 279 (2004) 48477-48485
116. Tam S.P., Mok L., Chimini G., Vasa M., and Deeley R.G. ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells. Am. J. Physiol. Cell Physiol. 291 (2006) C490-C502
117. Clement A.B., Gamerdinger M., Tamboli I.Y., Lutjohann D., Walter J., Greeve I., Gimpl G., and Behl C. Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function. J. Neurochem. 111 (2009) 669-682
118. C.M. Cartagena, M.P. Burns, G.W. Rebeck, 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury, Brain Res. 1319 (2010) 1-12.
119. Liu J.P., Tang Y., Zhou S., Toh B.H., McLean C., and Li H. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol. Cell. Neurosci. 43 (2009) 33-42
120. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
121. Jick H., Zornberg G.L., Jick S.S., Seshadri S., and Drachman D.A. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
122. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57 (2000) 1439-1443
123. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
124. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., and Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5856-5861
125. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., Tint G.S., Wang R., Mercken M., Petanceska S.S., and Duff K.E. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8 (2001) 890-899
126. Wolozin B. Cholesterol and Alzheimer's disease. Biochem. Soc. Trans. 30 (2002) 525-529
127. Cucchiara B., and Kasner S.E. Use of statins in CNS disorders. J. Neurol. Sci. 187 (2001) 81-89
128. Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T., Behl C., Levkau B., and Nitsch R.M. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 20 (2000) 7345-7352
129. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
130. Urano Y., Hayashi I., Isoo N., Reid P.C., Shibasaki Y., Noguchi N., Tomita T., Iwatsubo T., Hamakubo T., and Kodama T. Association of active gamma-secretase complex with lipid rafts. J. Lipid Res. 46 (2005) 904-912
131. Abad-Rodriguez J., Ledesma M.D., Craessaerts K., Perga S., Medina M., Delacourte A., Dingwall C., De Strooper B., and Dotti C.G. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167 (2004) 953-960
132. Crameri A., Biondi E., Kuehnle K., Lutjohann D., Thelen K.M., Perga S., Dotti C.G., Nitsch R.M., Ledesma M.D., and Mohajeri M.H. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J. 25 (2006) 432-443
133. Ledesma M.D., Abad-Rodriguez J., Galvan C., Biondi E., Navarro P., Delacourte A., Dingwall C., and Dotti C.G. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep. 4 (2003) 1190-1196
134. Bulloj A., Leal M.C., Surace E.I., Zhang X., Xu H., Ledesma M.D., Castano E.M., and Morelli L. Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation. Mol. Neurodegener. 3 (2008) 22
135. Wu C., Miloslavskaya I., Demontis S., Maestro R., and Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432 (2004) 640-645
136. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci. 60 (2003) 1158-1171
137. Corder E.H., Ghebremedhin E., Taylor M.G., Thal D.R., Ohm T.G., and Braak H. The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann. N. Y. Acad. Sci. 1019 (2004) 24-28
138. Kang D.E., Pietrzik C.U., Baum L., Chevallier N., Merriam D.E., Kounnas M.Z., Wagner S.L., Troncoso J.C., Kawas C.H., Katzman R., and Koo E.H. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Invest. 106 (2000) 1159-1166
139. Ma S.L., Ng H.K., Baum L., Pang J.C., Chiu H.F., Woo J., Tang N.L., and Lam L.C. Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease. Neurosci. Lett. 332 (2002) 216-218
140. Utermann G., Langenbeck U., Beisiegel U., and Weber W. Genetics of the apolipoprotein E system in man. Am. J. Hum. Genet. 32 (1980) 339-347
141. Poirier J. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease. Alzheimers Dement. 4 (2008) S91-S97
142. Lomnitski L., Chapman S., Hochman A., Kohen R., Shohami E., Chen Y., Trembovler V., and Michaelson D.M. Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. Biochim. Biophys. Acta 1453 (1999) 359-368
143. DeMattos R.B. Apolipoprotein E dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 23 (2004) 255-262
144. Veinbergs I., and Masliah E. Synaptic alterations in apolipoprotein E knockout mice. Neuroscience 91 (1999) 401-403
145. Iadecola C. Rescuing troubled vessels in Alzheimer disease. Nat. Med. 11 (2005) 923-924
146. Marzolo M.P., and Bu G. Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin. Cell Dev. Biol. 20 (2009) 191-200
147. Li Y., Marzolo M.P., van Kerkhof P., Strous G.J., and Bu G. The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein. J. Biol. Chem. 275 (2000) 17187-17194
148. Liu C.X., Li Y., Obermoeller-McCormick L.M., Schwartz A.L., and Bu G. The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J. Biol. Chem. 276 (2001) 28889-28896
149. May P., Reddy Y.K., and Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277 (2002) 18736-18743
150. von Arnim C.A., Kinoshita A., Peltan I.D., Tangredi M.M., Herl L., Lee B.M., Spoelgen R., Hshieh T.T., Ranganathan S., Battey F.D., Liu C.X., Bacskai B.J., Sever S., Irizarry M.C., Strickland D.K., and Hyman B.T. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J. Biol. Chem. 280 (2005) 17777-17785
151. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., Spijkers P., Guo H., Song X., Lenting P.J., Van Nostrand W.E., and Zlokovic B.V. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43 (2004) 333-344
152. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., and Zlokovic B.V. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106 (2000) 1489-1499
153. Beffert U., Stolt P.C., and Herz J. Functions of lipoprotein receptors in neurons. J. Lipid Res. 45 (2004) 403-409
154. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., and Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24 (1999) 481-489
155. Chang T.Y., Chang C.C., and Cheng D. Acyl-coenzyme A:cholesterol acyltransferase. Annu. Rev. Biochem. 66 (1997) 613-638
156. Olofsson S.O., Bostrom P., Andersson L., Rutberg M., Perman J., and Boren J. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim. Biophys. Acta 1791 (2009) 448-458
157. Puglielli L., Konopka G., Pack-Chung E., Ingano L.A., Berezovska O., Hyman B.T., Chang T.Y., Tanzi R.E., and Kovacs D.M. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat. Cell Biol. 3 (2001) 905-912
158. Hutter-Paier B., Huttunen H.J., Puglielli L., Eckman C.B., Kim D.Y., Hofmeister A., Moir R.D., Domnitz S.B., Frosch M.P., Windisch M., and Kovacs D.M. The ACAT inhibitor CP-113, 818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44 (2004) 227-238
159. Bose C., Bhuvaneswaran C., and Udupa K.B. Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK. Mech. Ageing Dev. 126 (2005) 740-751
160. Liu L., Bortnick A.E., Nickel M., Dhanasekaran P., Subbaiah P.V., Lund-Katz S., Rothblat G.H., and Phillips M.C. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278 (2003) 42976-42984
161. Wollmer M.A., Streffer J.R., Lutjohann D., Tsolaki M., Iakovidou V., Hegi T., Pasch T., Jung H.H., Bergmann K., Nitsch R.M., Hock C., and Papassotiropoulos A. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol. Aging 24 (2003) 421-426
162. Papassotiropoulos A., Streffer J.R., Tsolaki M., Schmid S., Thal D., Nicosia F., Iakovidou V., Maddalena A., Lutjohann D., Ghebremedhin E., Hegi T., Pasch T., Traxler M., Bruhl A., Benussi L., Binetti G., Braak H., Nitsch R.M., and Hock C. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch. Neurol. 60 (2003) 29-35
163. Hirsch-Reinshagen V., Zhou S., Burgess B.L., Bernier L., McIsaac S.A., Chan J.Y., Tansley G.H., Cohn J.S., Hayden M.R., and Wellington C.L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279 (2004) 41197-41207
164. Karasinska J.M., Rinninger F., Lutjohann D., Ruddle P., Franciosi S., Kruit J.K., Singaraja R.R., Hirsch-Reinshagen V., Fan J., Brunham L.R., Bissada N., Ramakrishnan R., Wellington C.L., Parks J.S., and Hayden M.R. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 29 (2009) 3579-3589
165. Koldamova R.P., Lefterov I.M., Ikonomovic M.D., Skoko J., Lefterov P.I., Isanski B.A., DeKosky S.T., and Lazo J.S. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278 (2003) 13244-13256
166. Zelcer N., Khanlou N., Clare R., Jiang Q., Reed-Geaghan E.G., Landreth G.E., Vinters H.V., and Tontonoz P. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10601-10606
167. Wahrle S.E., Jiang H., Parsadanian M., Hartman R.E., Bales K.R., Paul S.M., and Holtzman D.M. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J. Biol. Chem. 280 (2005) 43236-43242
168. Brown III J., Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J.M., Yager D., Crowley J., Sambamurti K., Rahman M.M., Reiss A.B., Eckman C.B., and Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279 (2004) 34674-34681
169. Heverin M., Bogdanovic N., Lutjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., and Bjorkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45 (2004) 186-193
170. Prasanthi J.R., Huls A., Thomasson S., Thompson A., Schommer E., and Ghribi O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol. Neurodegener. 4 (2009) 1
171. Group H.P.S.C. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
172. Yaffe K., Barrett-Connor E., Lin F., and Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch. Neurol. 59 (2002) 378-384
173. Sparks D.L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Browne P., Wasser D., Johnson-Traver S., Lochhead J., and Ziolwolski C. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch. Neurol. 62 (2005) 753-757
174. Peri A., and Serio M. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1. J. Mol. Endocrinol. 41 (2008) 251-261
175. Luciani P., Gelmini S., Ferrante E., Lania A., Benvenuti S., Baglioni S., Mantovani G., Cellai I., Ammannati F., Spada A., Serio M., and Peri A. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 90 (2005) 6156-6161
176. Yaffe K., Krueger K., Cummings S.R., Blackwell T., Henderson V.W., Sarkar S., Ensrud K., and Grady D. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am. J. Psychiatry 162 (2005) 683-690
177. Resnick S.M., and Henderson V.W. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 288 (2002) 2170-2172
178. Voytko M.L., Murray R., and Higgs C.J. Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone. J. Neurosci. 29 (2009) 10362-10370
179. Woolley C.S. Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 657-680
180. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43 (1993) 1609-1611
181. Risner M.E., Saunders A.M., Altman J.F., Ormandy G.C., Craft S., Foley I.M., Zvartau-Hind M.E., Hosford D.A., and Roses A.D. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 6 (2006) 246-254
182. Bu G., and Schwartz A.L. RAP, a novel type of ER chaperone. Trends Cell Biol. 8 (1998) 272-276
183. Ulery P.G., Beers J., Mikhailenko I., Tanzi R.E., Rebeck G.W., Hyman B.T., and Strickland D.K. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J. Biol. Chem. 275 (2000) 7410-7415
184. Lutjohann D., and von Bergmann K. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 36 Suppl 2 (2003) S102-S106
185. Qing H., He G., Ly P.T., Fox C.J., Staufenbiel M., Cai F., Zhang Z., Wei S., Sun X., Chen C.H., Zhou W., Wang K., and Song W. Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J. Exp. Med. 205 (2008) 2781-2789
186. Leoni V., Shafaati M., Salomon A., Kivipelto M., Bjorkhem I., and Wahlund L.O. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?. Neurosci. Lett. 397 (2006) 83-87
187. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39 (2007) 17-23